# Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation

> **NCT07050212** · NA · RECRUITING · sponsor: **Maternal and Child Health Hospital of Hubei Province** · enrollment: 150 (estimated)

## Conditions studied

- Remimazolam
- Dexmedetomidine
- Esketamine

## Interventions

- **DRUG:** remimazolam group
- **DRUG:** dexmedetomidine group
- **DRUG:** esketamine group

## Key facts

- **NCT ID:** NCT07050212
- **Lead sponsor:** Maternal and Child Health Hospital of Hubei Province
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050212, "Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07050212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*